TGFB1 and scleroderma: These findings indicate that in the context of TGF-β-induced profibrotic responses, Nab2 functions as an important negative regulator, and impaired Nab2 expression or function in activated dermal fibroblasts might contribute to the persistence or progression of skin fibrosis in scleroderma.